tiprankstipranks
Pro Medicus Limited (AU:PME)
ASX:PME
Australian Market

Pro Medicus Limited (PME) Financial Statements

Compare
106 Followers

Pro Medicus Limited Financial Overview

Pro Medicus Limited's market cap is currently $28.43B. The company's EPS TTM is AU$0.792; its P/E ratio is 343.17; and it has a dividend yield of 0.15%. Pro Medicus Limited is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is AU$0.48. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 161.50MAU$ 124.90MAU$ 93.46MAU$ 67.88MAU$ 56.82M
Gross ProfitAU$ 122.31MAU$ 92.37MAU$ 70.28MAU$ 46.66MAU$ 35.93M
Operating IncomeAU$ 112.18MAU$ 83.87MAU$ 62.39MAU$ 42.38MAU$ 30.07M
EBITDAAU$ 120.69MAU$ 94.05MAU$ 70.39MAU$ 50.07MAU$ 37.75M
Net IncomeAU$ 82.79MAU$ 60.65MAU$ 44.44MAU$ 30.85MAU$ 23.08M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 155.43MAU$ 121.50MAU$ 90.55MAU$ 61.82MAU$ 43.41M
Total AssetsAU$ 257.43MAU$ 202.13MAU$ 157.05MAU$ 125.57MAU$ 95.64M
Total DebtAU$ 2.07MAU$ 1.85MAU$ 2.28MAU$ 2.62MAU$ 2.28M
Net DebtAU$ -57.99MAU$ -89.40MAU$ -61.38MAU$ -39.42MAU$ -41.14M
Total LiabilitiesAU$ 69.70MAU$ 63.36MAU$ 55.32MAU$ 43.89MAU$ 35.46M
Stockholders' EquityAU$ 187.73MAU$ 138.78MAU$ 101.73MAU$ 81.68MAU$ 60.18M
Cash Flow
Free Cash FlowAU$ 80.08MAU$ 58.33MAU$ 53.20MAU$ 31.33MAU$ 23.72M
Operating Cash FlowAU$ 86.78MAU$ 64.77MAU$ 62.23MAU$ 39.02MAU$ 31.59M
Investing Cash FlowAU$ -78.07MAU$ -9.79MAU$ -17.56MAU$ -27.40MAU$ -7.87M
Financing Cash FlowAU$ -39.84MAU$ -27.53MAU$ -23.31MAU$ -14.05MAU$ -12.31M
Currency in AUD

Pro Medicus Limited Earnings and Revenue History

Pro Medicus Limited Debt to Assets

Pro Medicus Limited Cash Flow

Pro Medicus Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis